EE507 Integrated Budget Impact Analysis of Introducing Selpercatinib As a Tumor-Agnostic Treatment Option for Patients with RET-Altered Solid Tumors in the United States
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2486
https://www.valueinhealthjournal.com/article/S1098-3015(23)02676-1/fulltext
Title :
EE507 Integrated Budget Impact Analysis of Introducing Selpercatinib As a Tumor-Agnostic Treatment Option for Patients with RET-Altered Solid Tumors in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02676-1&doi=10.1016/j.jval.2023.03.2486
First page :
Section Title :
Open access? :
No
Section Order :
10281